Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87912 refers to the process of conducting an infectious agent genotype analysis specifically for the Hepatitis B virus (HBV) through nucleic acid testing, which can involve either DNA or RNA. This procedure is crucial for patients who have tested positive for HBV, a viral infection known for its potential to cause significant liver damage and increase the risk of liver cancer. The genotyping process involves amplifying and increasing the targeted DNA, which allows for the precise detection of the specific genotype of the virus. Understanding the genotype of HBV is essential as it can provide valuable prognostic information regarding the disease's progression and assist healthcare providers in determining the most appropriate antiviral treatment options for the patient. The analysis is performed on a blood sample, which is obtained through a separately reportable venipuncture. The serum or plasma from the blood sample is then subjected to testing methods such as polymerase chain reaction (PCR) or sequencing to accurately identify the HBV genotype.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure indicated by CPT® Code 87912 is performed for the following conditions:
The procedure for CPT® Code 87912 involves several key steps that ensure accurate genotype analysis of the Hepatitis B virus:
After the procedure associated with CPT® Code 87912, patients may experience minimal discomfort at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care requirements beyond standard care for a blood draw. Patients should be informed about the expected timeline for receiving test results and any follow-up appointments that may be necessary to discuss the findings and potential treatment options based on the genotype analysis. It is also important for healthcare providers to monitor the patient's liver function and overall health as part of ongoing management of HBV infection.
| Short Descr | NFCT AGT GNTYP ALYS HEP B | Medium Descr | NFCT AGENT GENOTYPE ALYS NUCLEIC ACD HEP B VIRUS | Long Descr | Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virus | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2023-01-01 | Note | Short and medium descriptions changed. |
| 2013-01-01 | Added | Added |
Get instant expert-level medical coding assistance.